Literature DB >> 22835557

Long-term outcomes after transmyocardial revascularization.

Dale R Tavris1, James Matthew Brennan, Art Sedrakyan, Yue Zhao, Sean M O'Brien, Eric D Peterson, Thomas P Gross, Danica Marinac-Dabic, Keith A Horvath.   

Abstract

BACKGROUND: Two independent reports documented substantially higher operative mortality associated with transmyocardial revascularization (TMR) when used in isolation than that reported in the premarket clinical trials. To clarify the state of the art, this article assesses temporal trends in the use of TMR, short-term and long-term outcomes, and outcomes stratified by procedure type (TMR only and TMR + coronary artery bypass graft [CABG]) and by the 2 specific TMR devices.
METHODS: The study population included all patients undergoing TMR in isolation or in combination with CABG at 435 cardiothoracic hospitals in the United States participating in the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) from January 2000 through November 2006 (n = 15,386). Analysis of long-term outcomes was accomplished through linkage to Medicare claims data. Short-term and long-term (7 years) adverse outcomes were assessed and compared between the 2 TMR device types.
RESULTS: The use of TMR in conjunction with CABG surgery is increasing. This study showed modest differences in short-term morbidity and mortality between the 2 devices. In combination with CABG, after risk adjustment, patients treated with the holmium:YAG laser (experienced a higher rate of operative mortality (3.5% vs 2.5%; adjusted hazard ratio 1.39, 95% confidence level 1.03 to 1.87) but no difference in the composite short-term rate of major morbidity or mortality, compared with the Heart Laser CO2 transmyocardial revascularization system (PLC Medical Systems, Inc, Milford, MA). However, there were no clinically meaningful differences in long-term results.
CONCLUSIONS: Modest differences in short-term morbidity and mortality between the 2 devices suggest the usefulness of further research.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22835557     DOI: 10.1016/j.athoracsur.2012.05.068

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Association of postoperative complications and outcomes following coronary artery bypass grafting.

Authors:  Oliver K Jawitz; Brian C Gulack; J Matthew Brennan; Dylan P Thibault; Alice Wang; Sean M O'Brien; Jacob N Schroder; Jeffrey G Gaca; Peter K Smith
Journal:  Am Heart J       Date:  2020-02-08       Impact factor: 4.749

Review 2.  Homogenization of Atrial Electrical Activities: Conceptual Restoration of Regional Electrophysiological Parameters to Deter Ischemia-Dependent Conflictogenic Atrial Fibrillation.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 3.  Transmyocardial revascularization devices: technology update.

Authors:  Bogdan A Kindzelski; Yifu Zhou; Keith A Horvath
Journal:  Med Devices (Auckl)       Date:  2014-12-18

Review 4.  Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging.

Authors:  Jessika Iwanski; Shannon M Knapp; Ryan Avery; Isabel Oliva; Raymond K Wong; Raymond B Runyan; Zain Khalpey
Journal:  J Cardiothorac Surg       Date:  2017-05-19       Impact factor: 1.637

Review 5.  Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapy.

Authors:  Jessika Iwanski; Raymond K Wong; Douglas F Larson; Alice S Ferng; Raymond B Runyan; Steven Goldstein; Zain Khalpey
Journal:  Springerplus       Date:  2016-06-16

6.  Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina.

Authors:  Janusz Konstanty-Kalandyk; Krzysztof Bartuś; Jacek Piątek; Venkat Vuddanda; Randall Lee; Anna Kędziora; Jerzy Sadowski; Dhanunjaya Lakkireddy; Bogusław Kapelak
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-06-19       Impact factor: 1.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.